Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
21461
-
21462
Table_1_A Cost-Effectiveness and Quality of Life Analysis of Different Approaches to the Management and Treatment of Localized Prostate Cancer.DOCX
Published 2020“…Microsimulations of radical prostatectomy, 3D-conformal radiotherapy, or active monitoring were performed using Medicare reimbursement schedules and clinical trial results for a target population of men aged 50–69 years with newly diagnosed localized prostate cancer (T1-T2, NX, M0) over a time horizon of 10 years. …”
-
21463
Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX
Published 2018“…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A ≥ 50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
-
21464
Table_1_Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.DOCX
Published 2018“…Three and one complete responses were observed at dose-levels “0” and “1,” respectively; the overall response rate (ORR) was 36% (4 of 11 patients). A ≥ 50% decrease in CXCR4 mean fluorescence intensity was observed in 4 of 9 patients by flow cytometry, indicating incomplete suppression of CXCR4-receptor occupancy.…”
-
21465
-
21466
-
21467
-
21468
-
21469
-
21470
-
21471
-
21472
-
21473
Prenatal Treatment of Mosaic Mice (Atp7a mo-ms) Mouse Model for Menkes Disease, with Copper Combined by Dimethyldithiocarbamate (DMDTC)
Published 2012“…In the present study we found that prenatal treatment of <em>mosaic</em> murine fetuses throughout gestation days 7, 11, 15 and 18 with a combination of CuCl<sub>2</sub> (50 mg/kg) and dimethyldithiocarbamate (DMDTC) (280 mg/kg) leads to an increase in survival to about 76±25.3 days, whereas treatment with CuCl<sub>2</sub> alone (50 mg/kg) only leads to survival for about 21 days ±5 days. …”
-
21474
-
21475
-
21476
-
21477
Two-dimensional RVE.
Published 2024“…The change in the mean maximum tensile stress of the capsule wall caused by the change of capsule diameter was within 5%. …”
-
21478
Deflection curves of the cantilever beam.
Published 2024“…The change in the mean maximum tensile stress of the capsule wall caused by the change of capsule diameter was within 5%. …”
-
21479
Parameters of the capsule under different cases.
Published 2024“…The change in the mean maximum tensile stress of the capsule wall caused by the change of capsule diameter was within 5%. …”
-
21480
Parameters of pavement structure.
Published 2024“…The change in the mean maximum tensile stress of the capsule wall caused by the change of capsule diameter was within 5%. …”